Maybe GSK will be next then again maybe they have already been in discussions for a considerable time. JPMHC is always heavily infiltrated by swarms of the big pharmas scouts & according to Doug Wilson last year it provided plenty of leads & opened up up many potential partners, of course though as is always the case the due dilligence many carry out before formally agreeing to deals & putting ink to paper is usually ~12 months so i guess the most favourable outcome would be GSK has already been in discussion for a considerable length of time maybe even as long ago as what was initiated as a result of JPMHC in 2011 ? We already know there is a long line of companies in discussion with PYC it just comes down to when they put the signatures on the paper. Hopefully this years conference was more of a "hello" to those already in discussion than a drum up of new leads.
PYC Price at posting:
3.8¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)